Treatment with Soluble Tumor Necrosis Factor Receptor (sTNFR):Fc/p80 Fusion Protein Ameliorates Relapsing-remitting Experimental Autoimmune Encephalomyelitis and Decreases Chemokine Expression

References

• Hofman, F.M., Hinton, DR., Johnson, K. and Merrill, J.E. (1989) "Tumor necrosis factor identified in multiple sclerosis brain", J. Exp. Med. 170, 607–612.
   PubMed Web of Science ®Google Scholar
• Selmaj, K., Raine, CS., Canella, B. and Brosnan, C.F. (1991) "Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions", J. Clin. Investig. 87, 949–954.
   PubMed Web of Science ®Google Scholar
• Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M. and Olsson, T. (1995) "Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-12, cytolysin, tumor necrosis factor a and tumor necrosis factor b", J. Neuroimmuna 61, 205–212.
   PubMed Web of Science ®Google Scholar
• Sharief, M. and Hentges, R. (1991) "Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis", N. EngL J. Med. 325, 467–472.
   PubMed Web of Science ®Google Scholar
• Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H. and Wietzerbin, J. (1988) "Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation inmultiple sclerosis: do cytokines trigger off exacerbation?", Acta Neurol. Scand. 78, 318–323.
   PubMed Web of Science ®Google Scholar
• Chofflon, M., Juillard, C., Juillard, P., Gauthier, G. and Gar, G.E. (1992) "Tumor necrosis factor a production as a possible predictor of relapse in patients with multiple sclerosis", Eur. Cytokine Netw. 3, 523–531.
   PubMedGoogle Scholar
• Glabinski, A., Mirecka, M. and Pokoca, L. (1995) "TNF alpha but not lymphotoxin is overproduced in multiple sclerosis", Acta Neurol. Scand. 91, 276–279.
   PubMed Web of Science ®Google Scholar
• Selmaj, K.W. and Raine, C.S. (1988) "Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro", Ann. Neurol. 23, 339–346.
   PubMed Web of Science ®Google Scholar
• Ruddle, N.H., Bergman, CM., McGrath, KM., Lingenheld, E.G. and Grunnet, M.L. (1990) "An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental autoimmune encephalomyelitis", J. Exp. Med. 174, 1193–1200.
   Google Scholar
• Selmaj, K., Raine, C.S. and Cross, A.H. (1991) "Anti-tumor necrosis factor therapy abrogates autoimmune demyelination", Ann. Neurol. 30, 694–700.
   PubMed Web of Science ®Google Scholar
• Tartaglia, A. and Goeddel, D.V. (1992) "Two TNF receptors", Immunol. Today 13, 151–153.
   PubMedGoogle Scholar
• Seckinger, P., Isaaz, S. and Dayer, J.M. (1988) "A human inhibitor of tumor necrosis factor a", J. Exp. Med. 167, 1511–1516.
   PubMed Web of Science ®Google Scholar
• Engelmann, RD., Aderka, D., Rubinstein, M., Rotman, D. and Wallach, D.A. (1989) "A tumor necrosis factor—binding protein purified to human urine protects cells from tumor necrosis factor toxicity", J. Biol. Chem. 264, 11974–11980.
   PubMed Web of Science ®Google Scholar
• Engelman, H., Novick, D. and Wallach, D. (1990) "Two tumor necrosis factor—binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors", J. Biol. Chem. 265, 1531–1536.
   PubMed Web of Science ®Google Scholar
• Seckinger, P., Zhang, J., Hauptmann, B. and Dayer, J.M. (1990) "Characterization of a tumor necrosis factor-a inhibitor: evidence of immunological cross-reactivity with the TNF receptor", Proc. Natl Acad. Sci. USA 87, 5188–5192.
   PubMed Web of Science ®Google Scholar
• Nophar, Y., Kemper, 0., Brakebusch, C., et al. (1990) "Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor", EMBO J. 9, 3269–3278.
   PubMed Web of Science ®Google Scholar
• Van Zee, K., Kohno, T., Fischer, E., Rock, C., Moldawer, L. and Lowry, S. (1992) "Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo", Proc. Natl Acad. Sci. USA 89, 4845–4849.
   PubMed Web of Science ®Google Scholar
• Mohler, KM., Torrance, D.S., Smith, C.A., et al. (1993) "Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simul-taneously as both TNF carriers and TNF antagonists", J. Immunol. 151, 1548–1561.
   PubMed Web of Science ®Google Scholar
• Selmaj, K., Papierz, W., Glabinski, A. and Kohno, T. (1995) "Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I", J. Neuroimmunol. 56, 135–141.
   PubMed Web of Science ®Google Scholar
• Peppel, K., Crawford, D. and Beutler, B. (1991) "A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity", J. Exp. Med. 174, 1483–1489.
   PubMed Web of Science ®Google Scholar
• Abraham, E., Coulson, W.F., Schwartz, M.D. and Allbee, J. (1994) "Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation", Clin. Exp. Immunol. 98, 29–34.
   PubMed Web of Science ®Google Scholar
• Fisher, C.J.J., Agosti, J.M., Opal, S.M., et al. (1996) "Treatment of septic shock with the tumor necrosis factor receptor:fc fusion protein", N. Engl. J. Med. 334, 1697–1702.
   PubMed Web of Science ®Google Scholar
• Moreland, LW., Baumgartner, S.W., Schiff, M.H., et al. (1997) "Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein", N. EngL J. Med. 337, 141–147.
   PubMed Web of Science ®Google Scholar
• Karpus, W.J. (1999) "Chemokine regulation of inflammatory-mediated nervous system diseases", J. NeuroviroL 5, 1–2.
   PubMed Web of Science ®Google Scholar
• Glabinski, A. and Ransohoff, R. (1999) "Chemokines and chemokine receptors in CNS pathology", J. Neurovirol. 5, 3–12.
   PubMed Web of Science ®Google Scholar
• Bacon, KB. and Harrison, J.K. (2000) "Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis", J. Neuroimmunol. 104, 92–97.
   PubMed Web of Science ®Google Scholar